JPRN-UMIN000018406招募中未知
Efficacy and safety of switching from entecavir to tenofovir for chronic hepatitis B patients with sustained viral supression: a randomized controlled trial - Switching from entecavir to tenofovir for CHB patients with sustained viral supression
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Hypersensitivity for tenofovir 2) Presence of renal impairment 3) Presence of hypophosphatemia 4) Poorly-controlled diabetes 5) Poorly-controlled hypertension 6) History of hepatocellular carcinoma 7) Ineligible patients by atending physician
研究者
相似试验
招募中
不适用
Efficacy of entecavir-to-tenofovir switching treatment to attain a drug-free state in chronic hepatitis B: a randomized controlled trialchronic hepatitis BJPRN-UMIN000021793Department of Hepatology, Osaka Metropolitan University90
已完成
不适用
Efficacy and safety after switching from tenofovir disoproxil fumarate to tenofovir alafenamide containing antiretroviral therapy in virologically suppressed HIV-infected patientsHIV infectionJPRN-UMIN000038177Kyushu University Hospital Department of General internal medicine120
进行中（未招募）
不适用
A Study of the Safety and Efficacy of Entecavir plus Tenofovir in Adults with Chronic Hepatitis B Virus Infection with Previous Nucleoside/Nucleotide Treatment Failure. - NDEUCTR2009-015705-40-ITBristol-Myers Squibb International Corporation125
招募中
不适用
Efficacy of preceding administration of Entecavir with PEG-IFN-alfa2a for patients with chronic hepatitis B, positive with HBe antigen in young aged populationsChronic hepatitis BJPRN-UMIN000020124Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine,26
进行中（未招募）
1 期
Switch from Efavirenz / emtricitabine / tenofovir difumarate taken once a day or alternate day to Bictegravir / emtricitabine / tenofovir alafenamide in HIV+ patients with suppressed viral load.HIV infectionMedDRA version: 20.0Level: LLTClassification code 10020441Term: Human immunodeficiency virus infection, unspecifiedSystem Organ Class: 100000004862EUCTR2018-003880-79-ITISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI240